RESUMO
A series of chiral analogues of bicalutamide bearing electrophilic groups (isothiocyanate, N-chloroacetyl, and N-bromoacetyl) on aromatic ring B of the parent molecule were synthesized. These compounds were designed as affinity ligands for the androgen receptor (AR). We prepared the (R)- and (S)-optical isomers of these compounds as pure enantiomers. The AR binding affinities of these compounds were measured in a competitive binding assay with the radiolabeled high-affinity AR ligand, [(3)H]mibolerone. In accordance with our previous results for the enantiomers of bicalutamide, we found that all (R)-isomers demonstrated much higher binding affinity to the AR as compared to their corresponding (S)-isomers. The para-substituted affinity ligands in ring B bound the AR with higher affinities than the corresponding meta-substituted analogues. Oxidation of thioester affinity ligands to their sulfonyl analogues for the para-substituted compounds decreased AR binding affinities and similar modification increased binding affinities for corresponding meta-analogues. The least potent para-substituted sulfonyl compounds had higher AR binding affinities than the most potent meta-substituted sulfonyl compounds. Overall, the para-substituted unoxidized molecules demonstrated the highest AR binding affinity. Subsequent research using AR exchange assays and Scatchard analyses showed that the isothiocyanate affinity ligands (R)-7, (R)-9, and (R)-10 reported herein are the first specific chemoaffinity ligands for the AR.
Assuntos
Antagonistas de Androgênios/síntese química , Anilidas/síntese química , Dissulfetos/síntese química , Isotiocianatos/síntese química , Receptores Androgênicos/metabolismo , Sulfonas/síntese química , Antagonistas de Androgênios/química , Antagonistas de Androgênios/metabolismo , Antagonistas de Receptores de Andrógenos , Anilidas/química , Anilidas/metabolismo , Animais , Dissulfetos/química , Dissulfetos/metabolismo , Técnicas In Vitro , Isotiocianatos/química , Isotiocianatos/metabolismo , Ligantes , Masculino , Nitrilas , Próstata/metabolismo , Ensaio Radioligante , Ratos , Ratos Sprague-Dawley , Estereoisomerismo , Relação Estrutura-Atividade , Sulfonas/química , Sulfonas/metabolismo , Compostos de TosilRESUMO
To facilitate the rational design of novel and more potent androgen receptor ligands, three-dimensional models for the human androgen receptor ligand binding domain bound to testosterone have been developed. These models of the androgen receptor were based on the crystal structure of the highly homologous human progesterone receptor ligand binding domain. The homology modeled androgen receptor was refined using unrestrained multiple molecular dynamics simulations in explicit solvent. Key H-bonding partners with the 17-hydroxy group and 3-keto group of testosterone are Asn705 and Thr877, and Gln711 and Arg752, respectively. These models show the presence of a unique unoccupied cavity within the androgen receptor binding pocket which may be valuable in the development of novel selective androgen receptor ligands. A qualitative analysis of amino acid mutations within the hAR binding pocket that affect ligand binding are consistent with these androgen receptor models. In addition to testosterone, the binding modes of several hydroxyflutamide-like nonsteroidal ligands for the androgen receptor are investigated using flexible docking with FlexX followed by refinement of the initial complexes with molecular dynamics simulations. These docking studies indicate that Asn705 is an important determinant in binding hydroxyflutamide and its derivatives by participating in H-bond interactions with the alpha-hydroxy moiety of these ligands. In addition, the nitro functionality mimics the 3-keto group of the natural ligand testosterone and is involved in H-bonding interactions with Gln711 and Arg752. From these docking studies, we suggest a mechanism for the enantioselective binding of chiral hydroxyflutamide derivatives and expand upon the previously reported structure-activity relationship for hydroxyflutamide and its derivatives.
Assuntos
Flutamida/química , Imidazolidinas , Receptores Androgênicos/química , Substituição de Aminoácidos , Sítios de Ligação , Ligação Competitiva , Cristalografia por Raios X , Flutamida/análogos & derivados , Flutamida/síntese química , Humanos , Imidazóis/química , Ligantes , Modelos Moleculares , Mutação , Conformação Proteica , Estrutura Terciária de Proteína , Receptores Androgênicos/genética , Receptores de Progesterona/química , Estereoisomerismo , Relação Estrutura-AtividadeRESUMO
We synthesized a series of potential chemoaffinity ligands for the androgen receptor (AR) by means of structural modifications of bicalutamide, a known nonsteroidal antiandrogen used in the treatment of hormone-dependent prostate cancer. We determined AR binding affinities of these ligands, identified chemoaffinity ligands by exchange assays, and confirmed irreversible binding to the AR by Scatchard analyses. AR binding affinity was determined in a competitive binding assay with a radiolabeled high-affinity AR ligand, [3H]mibolerone ([3H]MIB). For exchange assays, AR were incubated with an excess of each ligand, and then adsorbed onto hydroxyapatite (HAP). HAP-bound AR then were incubated with [3H]MIB to determine the remaining exchangeable specific binding sites. To determine the concentration of binding sites (Bmax), using Scatchard analysis, AR were incubated with a fixed concentration of ligand and increasing [3H]MIB concentrations. The ligands showed a wide range of AR binding affinities. In the exchange assays, three isothiocyanate derivatives of R-bicalutamide, the p-isothiocyanate (R-4), the p-thio-isothiocyanate (R-6), and the m-isothiocyanate (R-3), reduced exchangeable specific binding of [3H]MIB by 85, 84, and 50%, respectively. The S-isomer of p-thio-isothiocyanate (S-6), which showed 700-fold lower AR binding affinity than R-6, did not reduce exchangeable specific binding of [3H]MIB. In Scatchard analyses, the isothiocyanate derivatives R-3, R-4, and R-6 showed significant and progressive reduction in Bmax at increasing concentrations. The results indicate that initial specific reversible AR binding was required for subsequent covalent labeling, and that R-3, R-4, and R-6 bound the AR specifically and irreversibly. These isothiocyanate derivatives of R-bicalutamide are the first specific chemoaffinity ligands for the AR, and will provide valuable tools for the molecular characterization of the ligand binding domain of the AR.
Assuntos
Marcadores de Afinidade/metabolismo , Antagonistas de Androgênios/metabolismo , Anilidas/metabolismo , Receptores Androgênicos/metabolismo , Anilidas/química , Animais , Ligação Competitiva , Ligantes , Masculino , Nandrolona/análogos & derivados , Nandrolona/farmacologia , Nitrilas , Ratos , Ratos Sprague-Dawley , Estereoisomerismo , Compostos de TosilRESUMO
The acid-catalysed (perchloric acid) hydrolysis of 1,2-epoxybutene-3 (EB) and of 1,2:3,4-diepoxybutane (DEB), two reactive epoxide metabolites of 1,3-butadiene (BD), was determined based on reaction of unchanged epoxide with 1-nitro-4-pyridyl-benzene (NBP). Related to different epoxide concentrations, both reactions were of first order. Related to different proton concentrations, second-order rate constants were obtained (approximately 10 s-1 M-1 perchloric acid for EB; approximately 0.01 s-1 M-1 perchloric acid for DEB). These data show a much higher chemical stability of DEB compared to EB. Moreover, EB and DEB were reacted at pH 7.2 in 10 mM TRIS buffer with deoxyguanosine (dG), guanosine (G) or calf thymus DNA. The unreacted epoxides (EB or DEB) present in the incubation mixtures with time were determined by gas chromatography. Consistent with the results of the acid-catalysed hydrolysis, the second-order rate constants for reaction with dG, G or DNA were more than 10-fold higher with EB, compared to those with DEB.
Assuntos
Carcinógenos/metabolismo , Compostos de Epóxi/metabolismo , DNA/metabolismo , Desoxiguanosina/metabolismo , Guanosina/metabolismoRESUMO
Monocyclic aromatic amines (MAAs) are environmental pollutants. Many of them are genotoxic and impose hazards to human health. The mutagenicity of more than 80 of these amines was reviewed with primary emphasis on evaluation by the Ames Salmonella/microsome testing system. Many amines are mutagenic in Salmonella tester strains TA98 and TA100, but S9 mix is required for activity for most of the active ones. 2,4-Diaminotoluene, 2,4-diaminoethylbenzene, and a few amines containing a nitro-group are direct mutagens. There are several quantitative structure-activity relationship (QSAR) models which rationalize mutagenicity of many aromatic amines and several parameters, such as the lowest unoccupied molecular orbital energy (ELUMO), highest occupied molecular orbital energy (EHOMO), and hydrophobicity that are important. What factors determine the minimum requirement for the compound to be mutagenic and what factors determine the extent of mutagenicity suggest questions for further study.
Assuntos
Aminas/química , Aminas/farmacologia , Mutagênicos/química , Mutagênicos/farmacologia , Compostos Heterocíclicos/química , Compostos Heterocíclicos/farmacologia , Humanos , Testes de Mutagenicidade , Relação Estrutura-AtividadeRESUMO
Nonsteroidal androgens have not been reported. During studies to identify affinity ligands for the androgen receptor in our laboratory, we synthesized several electrophilic nonsteroidal ligands for the androgen receptor and examined their receptor binding affinity and ability to stimulate receptor-mediated transcriptional activation. We found that three of these ligands (1) bound the androgen receptor with affinity similar to that of dihydrotestosterone (the endogenous ligand) and (2) mimicked the effects of dihydrotestosterone on receptor-mediated transcriptional activation (i.e., they were receptor agonists). These studies demonstrate that nonsteroidal ligands can be structurally modified to produce agonist activity. These ligands thus represent the first members of a novel class of androgens with potential therapeutic applications in male fertility and hormone replacement therapy.
Assuntos
Androgênios/metabolismo , Receptores Androgênicos/metabolismo , Androgênios/fisiologia , Anilidas/metabolismo , Animais , Ligação Competitiva , Di-Hidrotestosterona/metabolismo , Cinética , Ligantes , Masculino , Nandrolona/análogos & derivados , Nandrolona/metabolismo , Nitrilas , Ratos , Ratos Sprague-Dawley , Congêneres da Testosterona/metabolismo , Compostos de TosilRESUMO
1. The biologic activity of androgens is mediated through the formation of a non-covalent androgen receptor (AR)-steroid complex. Casodex and other antiandrogens inhibit formation of this complex and thus negate the role of endogenous steroids in androgen-dependent growth of prostate. 2. Casodex is currently available as a racemic mixture. The goal of this investigation was to determine the in vitro AR binding affinities of the individual isomers of Casodex. 3. The (R) or (S) isomers of Casodex were synthesized according to the general synthetic scheme proposed by Tucker et al. for (S)-Casodex, using (R) or (S)-proline as the chiral matrix respectively. 4. ARs were isolated from rat ventral prostate tissue by homogenization and differential centrifugation, and used as the receptor source. 5. AR binding studies were conducted by incubation of the cytosol with 1 nM 3H-mibolerone (a synthetic androgen) and increasing concentrations of each isomer (10(-12) - 10(-5) M). Bound radioligand was quantitated by liquid scintillation counting. 6. Ki for (R)-Casodex (11.0 +/- 1.5 nM) was about 30 times lower than that of (S)-Casodex (364 +/- 10 nM). Ki for the racemate was 20.2 +/- 2.0 nM. 7. This study demonstrated that (R)-Casodex has a higher binding affinity than its stereoisomer and suggests that the antiandrogenic activity of racemic Casodex is almost completely due to the (R)-isomer.